Vigil Neuroscience, Inc. (NASDAQ: VIGL) had its price target raised by analysts at Wedbush from $22.00 to $23.00. They now have an "outperform" rating on the stock.
Vigil Neuroscience, Inc. (NASDAQ: VIGL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $24.00 price target on the stock.
Vigil Neuroscience Announces $40 Million Strategic Investment from Sanofi
Augustine Therapeutics Raises EUR 17 Million in a Series A First Closing to Advance Lead Candidate Into Clinical Development in Neurological Diseases
These 2 ‘Strong Buy' Penny Stocks Are Poised for a Massive Rally, Say Analysts [Yahoo! Finance]